A company has developed an iPhone-like bioreactor that may have the potential to aid quality control to validate the efficacy of cell therapies. The flat bioreactor, which has an inner section to hold various cell types, is designed to give a real-time 3D view of the tumor environment.
According to Massimo Dominici, MD, professor of medical oncology and scientific founder of Rigenerand, the technology should allow the validation of cell and gene therapies.
